SELON Polarized 3D Large Screen Empowers the Successful Holding of the 22nd Chinese Cerebrovascular Disease Forum

Recently, the 22nd Chinese Cerebrovascular Disease Forum (CFCVD2025) and the 3rd National Continuing Education Conference on Neurointervention, jointly hosted by the Beijing Huizhijing Medical Promotion Center and the China Association for the Promotion of Human Health Science and Technology, and undertaken by Xuanwu Hospital of Capital Medical University and other institutions, was grandly held in Beijing from April 18 to 20.

This forum focused on basic research and diagnostic and therapeutic technologies for cerebrovascular diseases. Nearly 1,700 experts and scholars from relevant departments including neurosurgery, neurology, radiology, interventional medicine, pathology and medical imaging across more than 300 domestic hospitals attended the event. Centering on hot topics such as basic and clinical research of cerebrovascular diseases, the latest advances in interventional and surgical techniques, exploration of individualized treatment regimens, and multidisciplinary collaboration, the forum facilitated in-depth academic discussions and experience sharing. It serves as a key exchange platform for cerebrovascular disease research and clinical practice in China.

As an influential enterprise in the global 3D display industry, SELON Shares has long been committed to the innovative application of relevant technologies in the medical field.

During the keynote session of the conference, the presentation From Basic Cerebrovascular Knowledge to Clinical Application (3D) delivered by participating experts was demonstrated on advanced polarized 3D large screens, offering an entirely new visual perspective and technical approach for the diagnosis and treatment of cerebrovascular diseases.

Within the 3D anatomy and surgical demonstration area of the Chinese Cerebrovascular Disease Forum, the polarized 3D large display screens remain unaffected by signal transmission and environmental interference. They enable more accurate stereoscopic positioning, analysis and visualization of cerebrovascular lesions, providing strong support for the formulation of individualized treatment plans as well as surgical observation and academic training.

Many attending experts spoke highly of the advanced 3D surgical demonstration technology. They acknowledged its broad application potential in the future diagnosis and treatment of cerebrovascular diseases, and recognized its capacity to elevate the overall standard of clinical diagnosis and treatment.

The Chinese Cerebrovascular Disease Forum has always upheld and continuously innovated its development philosophy, achieving sustained breakthroughs in the field of cerebrovascular diseases.The introduction of advanced 3D demonstration technology has injected new vitality into the forum and brought new opportunities for the development of cerebrovascular disease diagnosis and treatment.In the future, SELON Shares will further increase investment in medical technology R&D, contributing to the advancement of China’s medical services to new heights.